Nigeria Animal Health and Veterinary Services Market Size, Share & Forecast, By Product Type, Animal Type & Service Type, 2026–2031

The Nigeria Animal Health and Veterinary Services Market is worth USD 1.17 billion in 2025. The value includes vaccines, pharmaceuticals, feed additives, diagnostics, equipment and professional veterinary services delivered to production and companion animals. Poultry, cattle, sheep and goats account for most spending because Nigeria combines very large animal populations with persistent disease-control requirements. Preventive-care utilization is expanding, although service access remains uneven outside major commercial clusters. The 2025 value therefore reflects both formal product sales and paid clinical, diagnostic and herd-health activity.

The market is projected to reach USD 1.82 billion by 2031, expanding at a 7.68% CAGR from 2026 to 2031. Growth is expected to accelerate gradually as vaccination coordination improves, diagnostic capacity broadens and local vaccine manufacturing reduces supply constraints. Intervention volume is forecast to rise faster than the historical period, while average revenue per intervention increases through a richer mix of diagnostics, specialist care and scheduled herd-health programs. The outlook assumes implementation of the national veterinary roadmap and continued formalization of product channels.

Profit pools will shift toward preventive care, diagnostics, local biologics and integrated herd-health management. Vaccines and scheduled farm programs create repeat demand, while rapid testing and laboratory services improve margins by supporting earlier treatment and lower mortality. Local production can reduce freight, foreign-exchange and cold-chain exposure, but requires quality systems and dependable public procurement. Companion-animal clinics will also expand in major cities, although production animals remain the larger revenue base. Providers that bundle products, testing, consultation and digital follow-up are positioned to capture more customer lifetime value.

The main risk is the interaction of rural access gaps, affordability pressure and inconsistent product quality. Farmers may delay professional care or self-treat when travel, consultation and medicine costs are high, reducing conversion into formal demand. Import dependence exposes suppliers to currency and logistics volatility, while counterfeit or substandard products weaken trust and treatment outcomes. Workforce distribution, laboratory capacity and field mobility also remain uneven. Successful operators need controlled channels, lower-cost service bundles, authentication systems and route-based delivery models that maintain clinical governance without making care unaffordable.

Nigeria ranks first in the selected peer set by 2025 market value, ahead of South Africa, Kenya, Ethiopia and Ghana under a broad products-and-services scope. Its advantage comes from the scale of poultry, cattle and small-ruminant populations, alongside policy momentum in vaccination and veterinary-service reform. South Africa retains stronger mature-market infrastructure, while Kenya and Ethiopia have established public animal-health networks. Nigeria's higher forecast growth reflects underpenetration and formalization potential, but execution depends on workforce capability, quality regulation, local manufacturing and reliable last-mile distribution.

The strongest driver is the combination of a very large livestock and poultry base with recurring disease-prevention needs. Nigeria has approximately 55 million cattle, 139 million goats, 65 million sheep and 685 million poultry, creating repeated demand for vaccination, parasiticides, anti-infectives, diagnostics and professional advice. Commercial poultry requires high-frequency biosecurity and health interventions, while dispersed pastoral and smallholder systems need affordable mobile delivery. Policy coordination through the 2026-2036 veterinary roadmap can convert this biological need into more consistent formal spending.